These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 29569294)
1. Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature. Espersen ADL; Noren-Nyström U; Abrahamsson J; Ha SY; Pronk CJ; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Palmqvist L; Hasle H Genes Chromosomes Cancer; 2018 Jul; 57(7):359-365. PubMed ID: 29569294 [TBL] [Abstract][Full Text] [Related]
2. t(7;12)(q36;p13) and t(7;12)(q32;p13)--translocations involving ETV6 in children 18 months of age or younger with myeloid disorders. Slater RM; von Drunen E; Kroes WG; Weghuis DO; van den Berg E; Smit EM; van der Does-van den Berg A; van Wering E; Hählen K; Carroll AJ; Raimondi SC; Beverloo HB Leukemia; 2001 Jun; 15(6):915-20. PubMed ID: 11417477 [TBL] [Abstract][Full Text] [Related]
5. Three-way complex translocations in infant acute myeloid leukemia with t(7;12)(q36;p13): the incidence and correlation of a HLXB9 overexpression. Park J; Kim M; Lim J; Kim Y; Han K; Lee J; Chung NG; Cho B; Kim HK Cancer Genet Cytogenet; 2009 Jun; 191(2):102-5. PubMed ID: 19446746 [TBL] [Abstract][Full Text] [Related]
6. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9. von Bergh AR; van Drunen E; van Wering ER; van Zutven LJ; Hainmann I; Lönnerholm G; Meijerink JP; Pieters R; Beverloo HB Genes Chromosomes Cancer; 2006 Aug; 45(8):731-9. PubMed ID: 16646086 [TBL] [Abstract][Full Text] [Related]
7. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols. Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680 [TBL] [Abstract][Full Text] [Related]
8. [Clinical Efficacy of NOPHO-AML 2004 Regimen for Treatment of Children with Acute Myelocytic Leukemia (Non-M3)]. Qiu KY; Liao XY; Huang K; Li Y; Weng WJ; Xu HG; Fang JP; Wu RH; Zhou DH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):375-381. PubMed ID: 29665901 [TBL] [Abstract][Full Text] [Related]
9. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials. Lie SO; Abrahamsson J; Clausen N; Forestier E; Hasle H; Hovi L; Jonmundsson G; Mellander L; Gustafsson G Br J Haematol; 2003 Jul; 122(2):217-25. PubMed ID: 12846889 [TBL] [Abstract][Full Text] [Related]
10. Graft versus leukemia effect after haploidentical HSCT in a MLL-negative infant AML with HLXB9/ETV6 rearrangement. Hauer J; Tosi S; Schuster FR; Harbott J; Kolb HJ; Borkhardt A Pediatr Blood Cancer; 2008 Apr; 50(4):921-3. PubMed ID: 17960638 [TBL] [Abstract][Full Text] [Related]
11. Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study. Molgaard-Hansen L; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H; Pediatr Blood Cancer; 2011 Dec; 57(7):1222-9. PubMed ID: 22095929 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22). Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833 [TBL] [Abstract][Full Text] [Related]
13. Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO-DBH-AML study. Bager N; Juul-Dam KL; Sandahl JD; Abrahamsson J; Beverloo B; de Bont ESJM; Ha SY; Jahnukainen K; Jónsson ÓG; Kaspers GL; Kovalova Z; Lausen B; De Moerloose B; Noren-Nyström U; Palle J; Saks K; Zeller B; Kjeldsen E; Hasle H Br J Haematol; 2018 Nov; 183(4):618-628. PubMed ID: 30406946 [TBL] [Abstract][Full Text] [Related]
14. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study. Skou AS; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros-Svennilson J; Nysom K; Hasle H; Pediatr Blood Cancer; 2014 Sep; 61(9):1638-43. PubMed ID: 24760750 [TBL] [Abstract][Full Text] [Related]
15. Backtracking NOM1::ETV6 fusion to neonatal pathogenesis of t(7;12) (q36;p13) infant AML. Bousquets-Muñoz P; Molina O; Varela I; Álvarez-Eguiluz Á; Fernández-Mateos J; Gómez A; Sánchez EG; Balbín M; Ruano D; Ramírez-Orellana M; Puente XS; Menéndez P; Velasco-Hernandez T Leukemia; 2024 Aug; 38(8):1808-1812. PubMed ID: 38806630 [No Abstract] [Full Text] [Related]
16. Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001. Forestier E; Heim S; Blennow E; Borgström G; Holmgren G; Heinonen K; Johannsson J; Kerndrup G; Andersen MK; Lundin C; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ; Br J Haematol; 2003 May; 121(4):566-77. PubMed ID: 12752097 [TBL] [Abstract][Full Text] [Related]
17. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201 [TBL] [Abstract][Full Text] [Related]
18. Extramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). Støve HK; Sandahl JD; Abrahamsson J; Asdahl PH; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Hasle H Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28333413 [TBL] [Abstract][Full Text] [Related]
19. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study. Molgaard-Hansen L; Skou AS; Juul A; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H; Pediatr Blood Cancer; 2013 Dec; 60(12):1988-95. PubMed ID: 24038890 [TBL] [Abstract][Full Text] [Related]
20. Aberrant MNX1 expression associated with t(7;12)(q36;p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation. Waraky A; Östlund A; Nilsson T; Weichenhan D; Lutsik P; Bähr M; Hey J; Tunali G; Adamsson J; Jacobsson S; Morsy MHA; Li S; Fogelstrand L; Plass C; Palmqvist L Haematologica; 2024 Mar; 109(3):725-739. PubMed ID: 37317878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]